Regeneron Pharmaceuticals... (REGN)
NASDAQ: REGN
· Real-Time Price · USD
580.43
14.46 (2.55%)
At close: Aug 15, 2025, 3:59 PM
579.00
-0.25%
After-hours: Aug 15, 2025, 07:57 PM EDT
Regeneron Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 1.39B | 808.7M | 917.7M | 1.34B | 1.43B | 722M | 1.16B | 1.01B | 968.4M | 817.8M | 1.2B | 1.32B | 852.1M | 973.5M | 2.23B | 1.63B | 3.1B | 1.12B |
Depreciation & Amortization | 135.1M | 126.9M | 126.4M | 121.7M | 120.7M | 114.1M | 113M | 105.4M | 103.1M | 99.5M | 100.1M | 92.6M | 74.4M | 74.3M | 74.5M | 73.2M | 71.1M | 67.4M |
Stock-Based Compensation | 251.7M | 255.7M | 304.4M | 225.1M | 223.2M | 230.1M | 240.4M | 203.9M | 202M | 238.7M | 232M | 166.3M | 159.8M | 166.9M | 188.4M | 136.9M | 145.5M | 130.9M |
Other Working Capital | -373.6M | -161.8M | -76.5M | 826.9M | -437.2M | 39M | 43M | 45.3M | -17.9M | -41.4M | -40.9M | 103.5M | -143.5M | -35.3M | 27.1M | -45.4M | -149M | -193.6M |
Other Non-Cash Items | -270.9M | -136.7M | 280.9M | -695.6M | -395.6M | 196.2M | -75.6M | 115.2M | 39.5M | 187.2M | 88.4M | -192.8M | 415.4M | 288.8M | 441.9M | 101.1M | -245.6M | -115.7M |
Deferred Income Tax | -135.2M | -139.1M | -280.2M | -168.6M | -118.1M | -190.4M | -286.3M | -125.7M | -209.3M | -216.5M | -279.7M | -85.7M | -156M | -225M | -205.9M | 7M | 41.7M | 10.1M |
Change in Working Capital | -227.9M | 129.6M | -86.4M | 468M | -908.5M | 440.5M | -61.4M | -192.3M | -81.3M | 240.9M | 382M | -667.2M | -781.3M | 823.2M | -355.4M | 1.46B | -2.48B | -539.4M |
Operating Cash Flow | 1.14B | 1.05B | 1.26B | 1.29B | 354M | 1.51B | 1.09B | 1.11B | 1.02B | 1.37B | 1.72B | 628.9M | 564.4M | 2.1B | 2.37B | 3.41B | 626.7M | 668.5M |
Capital Expenditures | -176.8M | -271.5M | -267M | -183.6M | -210.9M | -161.8M | -313.5M | -176M | -113M | -178.2M | -152.2M | -142.5M | -153.6M | -141.8M | -154.9M | -133.2M | -148.5M | -115.3M |
Cash Acquisitions | n/a | n/a | -11.5M | -20.1M | 15.1M | n/a | -3.8M | 199.9M | 133.9M | 100.9M | 1.62B | -1.26B | -230.3M | 1.56B | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.86B | -2.54B | -1.95B | -4.59B | -4.42B | -5.66B | -2.13B | -3.24B | -4.52B | -1.75B | -3.14B | -570.1M | -1.47B | -2.31B | -2.18B | -2.99B | -526.5M | -1.36B |
Sales Maturities Of Investments | 2.17B | 3.46B | 2.58B | 4.26B | 4.05B | 4.13B | 2.38B | 3B | 2.27B | 1.79B | 1.54B | 1.83B | 1.44B | 746.3M | 318M | 680.2M | 800.8M | 416.3M |
Other Investing Acitivies | -187.8M | -42.2M | n/a | -38.2M | n/a | n/a | n/a | -274.9M | -154.8M | -201.8M | -1.72B | 334.8M | n/a | -1.56B | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.09B | 647.5M | 350.6M | -574.4M | -557.2M | -1.69B | -66.2M | -496.3M | -2.39B | -235.7M | -1.86B | 192.3M | -413.9M | -1.71B | -2.01B | -2.44B | 125.8M | -1.06B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -1.06B | -1.05B | -1.23B | -735.1M | -915.7M | -291.3M | -747.1M | -675.9M | -704.9M | -807.7M | -620.2M | -1.04B | -407.9M | -456.9M | -1.45B | -436M | -331.4M | -461.4M |
Dividend Paid | -92.6M | -93.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.6M | -10.3M | n/a | -153.6M | n/a | -343.7M | -458.1M | -129.4M | -16.1M | -97M | -189.1M | -108.9M | -48.9M | -98.8M | -582.4M | -269.6M | -26.2M | -154.5M |
Financial Cash Flow | -1.13B | -1.09B | -1.14B | -634M | -478.1M | 47.1M | -446.1M | -407.3M | -614.2M | -322.5M | -247.6M | -725M | -101.1M | 64.7M | -906.6M | 385.4M | -118.2M | -366.4M |
Net Cash Flow | -1.08B | 604M | 477.2M | 83.6M | -681.6M | -128M | 577.6M | 210.5M | -1.98B | 809.4M | -385.4M | 96.2M | 49.4M | 461.1M | -546.8M | 1.36B | 634.3M | -756.9M |
Free Cash Flow | 967.6M | 773.6M | 995.8M | 1.11B | 143.1M | 1.35B | 776.2M | 938.3M | 909.4M | 1.19B | 1.57B | 486.4M | 410.8M | 1.96B | 2.22B | 3.28B | 478.2M | 553.2M |